Should I Buy ABEO Stock in 2026?
Data-driven analysis and honest assessment for Abeona Therapeutics Inc
Current Price: $5.31P/E: 4.3
Decision Score
Hold
Based on 6 fundamental factors
Score Breakdown:
Very low P/E of 4.3 suggests undervaluation
Declining -1%
Excellent margins (206% net)
Financial health data limited
Negative free cash flow
No recent insider activity
Key Investment Metrics
Current Price
$5.31
P/E Ratio
4.34
Revenue Growth
-1.0%
Profit Margin
205.9%
Market Cap
$0.3B
Dividend Yield
None
How ABEO Compares to Competitors
Understanding how ABEO stacks up against peers helps inform your investment decision.
How ABEO Compares to Peers
Upcoming Events for ABEO
+5 Reasons TO Buy ABEO
1. Attractively valued at 4.3x earnings
strongA P/E ratio of 4.3 is below the market average of ~20x, suggesting the stock may be undervalued.
2. Exceptional profit margins of 206%
strongNet margins above 20% indicate strong pricing power and competitive advantages.
-5 Reasons NOT to Buy ABEO
1. Negative free cash flow
high riskBurning cash creates funding risk and limits shareholder returns.
2. Small-cap volatility risk
high riskMarket cap under $2B means higher volatility and lower liquidity.
3. Revenue declining 1%
medium riskShrinking revenue suggests loss of market share or weakening demand. Turnarounds are difficult.
Who Should Buy ABEO?
Investment Profile
Risk Level
Very High
Recommended Holding Period
3-5 years
Best For:
- ✓
Value Investors
P/E of 4.3 offers margin of safety
Not Suitable For:
- ✗
Growth Investors
Limited -1% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
Very High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in ABEO, compare these Healthcare peers:
Pro tip: Compare ABEO directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for ABEO
Frequently Asked Questions
What is ABEO stock price today?
ABEO (Abeona Therapeutics Inc) stock is trading at $5.31 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is ABEO stock going up or down today?
ABEO stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy ABEO stock now?
The decision to buy ABEO depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is ABEO a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for ABEO based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is ABEO stock overvalued or undervalued?
ABEO currently trades at a P/E ratio of 4.34, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if ABEO is fairly priced.
What is ABEO's P/E ratio?
ABEO has a price-to-earnings (P/E) ratio of 4.34, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is ABEO's market cap?
ABEO (Abeona Therapeutics Inc) has a market capitalization of $0.28 billion, making it a small-cap stock.
What is ABEO's price to book ratio?
ABEO trades at a price-to-book (P/B) ratio of 1.66, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Abeona Therapeutics Inc
Full Stock Analysis
Complete ABEO overview with charts and data
Is ABEO Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how ABEO stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Abeona Therapeutics Inc
Complete ABEO Analysis
Compare ABEO With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.